https://www.zonebourse.com/cours/action/ELI-LILLY-AND-COMPANY-13401/actualite/La-FDA-approuve-l-OLUMIANT-baricitinib-de-Lilly-et-Incyte-pour-le-traitement-de-certains-patient-40412719/?utm_source=telegram&utm_medium=social&utm_campaign=share